Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.
about
Shigella Vaccine Development: Finding the Path of Least Resistance.Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016A Novel Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental ChallengeCross-Protective Whole-Cell Vaccine With a Truncated O-Polysaccharide Chain
P2860
Evaluation of the Safety, Tolerability, and Immunogenicity of an Oral, Inactivated Whole-Cell Shigella flexneri 2a Vaccine in Healthy Adult Subjects.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Evaluation of the Safety, Tole ...... ine in Healthy Adult Subjects.
@ast
Evaluation of the Safety, Tole ...... ine in Healthy Adult Subjects.
@en
type
label
Evaluation of the Safety, Tole ...... ine in Healthy Adult Subjects.
@ast
Evaluation of the Safety, Tole ...... ine in Healthy Adult Subjects.
@en
prefLabel
Evaluation of the Safety, Tole ...... ine in Healthy Adult Subjects.
@ast
Evaluation of the Safety, Tole ...... ine in Healthy Adult Subjects.
@en
P2093
P2860
P356
P1476
Evaluation of the Safety, Tole ...... ine in Healthy Adult Subjects.
@en
P2093
Barbara DeNearing
Clayton Harro
Jorge Flores
Lillian Van de Verg
Nicole Bauers
Richard Walker
Subhra Chakraborty
P2860
P304
P356
10.1128/CVI.00608-15
P577
2016-02-10T00:00:00Z